Coloplast AS (XTER:CBHD)
€ 123.2 1.15 (0.94%) Market Cap: 27.56 Bil Enterprise Value: 30.48 Bil PE Ratio: 40.61 PB Ratio: 11.45 GF Score: 92/100

Coloplast A/S Revised Full Year Organic Growth and EBIT Margin Guidance for 2019/2020 Call Transcript

Mar 19, 2020 / 07:00AM GMT
Release Date Price: €135.75 (+9.48%)
Operator

Ladies and gentlemen, thank you all for standing by, and welcome to today's Coloplast announcement. (Operator Instructions) I must advise you all that this conference is being recorded today, Thursday, the 19th of March 2020.

And without any further delay, I would like to hand the conference to your speaker today, the CEO, Kristian Villumsen. Please go ahead, sir.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you very much, operator, and good morning to everybody, and welcome to this morning's conference call. I'm Kristian Villumsen, CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. I'll start with a few opening remarks, and then Anders and I will open up for questions.

Last night, we issued a stock exchange announcement and revised our guidance for our financial year 2019/'20. These are no ordinary times. We're seeing the coronavirus spread across the world and the situation is developing rapidly.

Our priorities are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot